Overview

Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne

Status:
Completed

Trial end date:
2004-06-01

Target enrollment:

Participant gender:

Summary

The objectives of this study were to evaluate the efficacy and safety of drospirenone 3 mg/ethinyl estradiol 0.02 mg (DRSP/EE) in comparison with placebo in female subjects with moderate acne vulgaris during 6 treatment cycles

Phase:

Phase 3

Details

Lead Sponsor:

Bayer

Treatments:

Contraceptive Agents
Contraceptives, Oral